Fabien Corp (FBIO) Reports Q1 Loss of $0.31/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Fortress Biotech Reports Financial Results for the First Quarter 2015 Ended March 31, 2015
May 11, 2015 8:31 AM EDTNEW YORK, May 11, 2015 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) announces its financial results for the first quarter of 2015 ended March 31, 2015.
"This was a very busy and productive quarter as we continue to make progress with executing our business plan to develop a diversified biopharmaceutical company with a robust pipeline of products and multiple revenue streams. During the first quarter and the subsequent few weeks, we secured six key licensing agreements and formed three new subsidiaries, which we refer to as 'Fortress Companies,'" said Dr. Lindsay A. Rosenwald, Fortress Biotech's... More
